Esperion Therapeutics, Inc. financial data

Symbol
ESPR on Nasdaq
Location
3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116 % -37.2%
Quick Ratio 35.5 % -22.6%
Debt-to-equity -181 % +2.13%
Return On Equity 24.9 % +5.02%
Return On Assets -30.7 % -10.2%
Operating Margin -9.67 % -274%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 239M shares +21.3%
Entity Public Float 435M USD +205%
Common Stock, Value, Issued 205K USD +5.13%
Weighted Average Number of Shares Outstanding, Basic 201M shares +2.98%
Weighted Average Number of Shares Outstanding, Diluted 201M shares +2.98%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 304M USD +2.83%
Operating Income (Loss) -29.4M USD -279%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -106M USD -22%
Earnings Per Share, Basic 0 USD/shares -11.3%
Earnings Per Share, Diluted 0 USD/shares -3.64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.4M USD -36.1%
Accounts Receivable, after Allowance for Credit Loss, Current 119M USD +75.4%
Inventory, Net 109M USD +35.5%
Assets, Current 360M USD +17.2%
Property, Plant and Equipment, Net 175K USD -37.7%
Operating Lease, Right-of-Use Asset 3.33M USD -46.6%
Assets 364M USD +15.9%
Accounts Payable, Current 77.5M USD +122%
Employee-related Liabilities, Current 9.81M USD -11.9%
Contract with Customer, Liability, Current 30.7M USD +103%
Liabilities, Current 359M USD +116%
Operating Lease, Liability, Noncurrent 767K USD -76.8%
Other Liabilities, Noncurrent 7.44M USD
Liabilities 815M USD +19.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.69B USD -6.7%
Stockholders' Equity Attributable to Parent -451M USD -21.9%
Liabilities and Equity 364M USD +15.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.6M USD -142%
Net Cash Provided by (Used in) Financing Activities -7.5M USD -108%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 480M shares 0%
Common Stock, Shares, Issued 207M shares +5.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -30.1M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 92.4M USD -36.1%
Deferred Tax Assets, Valuation Allowance 413M USD +4.43%
Deferred Tax Assets, Gross 415M USD +4.51%
Operating Lease, Liability 5.31M USD +16.1%
Depreciation 26K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -106M USD -22%
Lessee, Operating Lease, Liability, to be Paid 5.75M USD +12.8%
Property, Plant and Equipment, Gross 2.33M USD +15.7%
Operating Lease, Liability, Current 2.38M USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.31M USD +27.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.06M USD +66.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 442K USD -16.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 241K USD -78.9%
Deferred Tax Assets, Operating Loss Carryforwards 204M USD -21.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.1M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 144K USD -14.8%
Additional Paid in Capital 1.29B USD +1.95%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 10.3M USD -22.3%
Interest Expense 58.6M USD +2.59%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%